Production of Type 2 Dengue (D2) Monoclonal Antibody and Cell Culture Derived D2 Antigen for Use in Dengue IgM-Capture ELISA by Igarashi Akira et al.
Trop. Med., 37 (4), 165-173, December, 1995 165
Production of Type 2 Dengue (D2) Monoclonal Antibody and
Cell Culture Derived D2 Antigen for Use in Dengue IgM-Capture ELISA
Akira IGARASHI1, Haliman MOHAMED2, Apandi YUSOF2,
Mangalam SINNIAH2, and Hiroshi TANAKA3
1 Department of Virology, Institute for Tropical Medicine, Nagasaki University,
1 - 12-4 Sakamoto, Nagasaki City, Japan 852
2 Division of Virology, Institute for Medical Research, Jalan Pahang, 50588 Kuala
Lumpur, Malaysia
3 IMR-JICA Project, Institute for Medical Research, Jalan Pahang, 50588 Kuala
Lumpur, Malaysia
Abstract: In order to strengthen laboratory diagnostic capability on dengue by IgM-ELISA in
Malaysia, type 2 dengue (D2) monoclonal antibody (MAb) and cell culture-derived D2 antigen
were prepared as culture fluid of hybridoma cell line and D2-infected C6/36 culture fluid,
respectively. Comparative IgM-ELISA was carried out on 90 serum specimens from dengue
patients using newly prepared reagents in comparison with routine reagents (D2-MAb mouse
ascitic fluid from CDC, USA, and D2 antigen extracted from infected suckling mouse brains).
The newly prepared MAb at 2-10 fold higher concentration than that estimated by antigen
detection ELISA, in combination with the undiluted D2-infected C6/36 cell culture fluid,
provided comparable sensitivity (93.3-97.9%) to that of routine reagents (90.0-98.5%).
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INTRODUCTION
Dengue virus infection has become a serious health problem in the tropics worldwide, be-
cause of (1) increasing number of patients, (2) enlarging epidemic areas, and (3) appearance of
severe clinical manifestation: dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS)
(World Health Organization, 1966; Halstead 1966, 1980, 1992, 1993). The laboratory diagnosis on
viral infection is important in order to provide accurate information to the clinicians for proper
case management, and to the epidemiologists and health administrators for efficient control
measures (Igarashi, 1994). In the laboratory diagnosis on dengue, classical hemagglutination-in-
hibition (HI) test (Clarke and Casals, 1985; Shope and Sather, 1979; World Health Organization,
1986) has gradually been replaced by or supplemented with IgM-ELISA (Burke, 1983; Bundo and
Igarashi, 1985; Lam et al, 1987; Innis et al, 1989). In the Division of Virology, Institute for
Medical Research (IMR), Malaysia, dengue IgM-ELISA has been used for routine diagnosis fol-
lowing the method of Lam et al (1987). One of its 2 key reagents, D2-MAb, was supplied by the
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courtesy from the Centers for Disease Control and Prevention (CDC), USA, and another reagent
has been produced from infected suckling mouse brains by classical extraction procedures (Clarke
and Casals, 1958), which is laborious, time consuming and requires animal handling and large
volume of organic solvent.
Strengthening of the diagnostic capability on dengue and Japanese encephalitis was planned
amongseveral objectives in the 3 years medical cooperation project by the Japan International
Cooperation Agency (JICA) which has been carried out at IMR since 1993. The production of
diagnostic reagents was listed under this objective, in order to improve current diagnostic
methods and distribute them to local laboratories in the future. Production of above-mentioned 2
key reagents was apparently a limiting factor for the achievement this objective.
Our previous communication (Mohamed et al, 1995b) showed that dengue cross-reactive
MAb (MF4/5A5/C3) and a cocktail of 4 dengue serotype antigens as infected cell culture fluids
can successfully be used in the IgM-ELISA with better sensitivity and similar specificity com-
pared with the current reagents. Later, these 2 reagents were utilized to produce commercial
dengue IgM-blot kit, and became difficult to get free of charge. In order to solve this problem, we
tried to produce these 2 key reagents in the Division of Virology, IMR.
MATERIALS AND METHODS
Virus: Dengue type 2 (D2) virus New Guinea B strain with multiple passages in C6/36 cell
line was used in the experiments. The seed virus was aliquoted and stored at -70°C.
Cell culture: The C6/36 cell line (Igarashi, 1978) was grown in screw-capped plastic flasks
at 28°C with Eagle's medium in Earle's saline supplemented with 9% heat-inactivated fetal calf
serum(FCS) and 0.2 mMeach nonessential amino acids. The PCS concentration was reduced to
2% in the maintenance medium after virus infection.
The hybridoma cell line (3H5-1-21) which secretes D2-specific MAb (Gentry et al, 1982;
Henchal et al, 1982) was kindly provided from Dr. Duane J. Gubler, Director, Vector-Borne
Disease Division, CDC, Ft. Collins, CO, USA. The cell line was grown at 37°C with the same
medium as C6/36 cells but increasing the FCS concentration to final 20%.
Antigen detection ELISA: The micro sandwich method of Voller et al (1878) was fol-
lowed with some modifications, using the reagent volume of 100^1/well and reaction step for 1
hour at room temperature unless otherwise specified. The flat-bottom 96 well ELISA plate (Nunc,
Denmark) was coated with antiflavivirus IgG diluted to 20^g/ml in the ELISA coating buffer
(0.05M carbonate-bicarbonate buffer, pH 9.6, containing 0.02% NaN3) at 4 °C overnight. The IgG
was prepared from a pool of high titered DHF patient's sera by chromatography on DEAE-
Sephacel column (Pharmacia, Sweden). The plate was inactivated with 4% skimmed milk in PBS
(-), followed by washing with PBS-T (0.05% Tween 20 in PBS (-)) 3 times 3 minutes each. The
test specimens, standard D2 antigen in serial 2-fold dilution, and mock-infected C6/36 cell culture
fluid as negative control were distributed in duplicate wells. The plate was washed as above,
followed by either of the 2 detection systems as described below.
In the detection system (1), the plate was reacted with antiflavivirus IgG which had been
167
conjugated with horseradish peroxidase (HRPO, Sigma, type "Vt, USA) according to Wilson and
Nakane (1878). The optimal dilution of the HRPO-conjugate waspredetermined by checkerboard
titration as described below. The plate was washed as above and HRPO reaction was carried out
using 0.05% o-phenylenediamine dihydrochloride and 0.01% H202 in 0.05 M citrate phosphate
buffer, pH 5.0, in the dark. After stopping the HRPO reaction with IN H2S04, the ELISA OD at
492 nm was recorded with 630 nm as a reference wavelength. The ELISA titer of the test
specimen was estimated by comparing its OD with those of serially diluted standard D2 antigen
(Igarashi et al. 1981; Morita et al, 1982). In the ckeckerboad titration, replicate wells were reacted
with D2-infected C6/36 cell culture fluid as positive specimen (P), or mock-infected C6/36 cell
culture fluid as negative specimen (N). After washing, the wells were reacted with HRPO-con-
jugated antiflavivirus IgG serially diluted in PBS-T, followed by washing and color development
as described above. The optimal diluiton of the HRPO-conjugate was determined as such that
provided the highest P/N ratio as well as the largest P-N difference in their ELISA OD.
In the detection system (2), the ELISA plate was reacted with anti-D2 MAb at appropriate
dilution, followed by washing as above. The plate was then reacted with HRPO-conjugated an-
ti-mouse IgG which is free from cross reaction to human IgG (Bio-Rad, USA). The plate was then
washed, and color development was carried out as described above.
IgM-capture ELISA: The ELISA plate was coated with n chain-specific anti-human IgM
goat IgG (Cappel, USA) diluted 1: 200 in coating buffer at 4°C overnight. The plate was inacti-
vated as in the antigen detection ELISA, followed by washing. The plate was reacted with test
sera or standard positive and negative sera at 1: 100 dilution in PBS-T. The plate was washed as
above, and followed by the detection system (2) as described in the antigen detection ELISA. The
HRPO-conjugated anti-mouose IgG was diluted to 1: 25,000 for the first test according to the
instruction of the manufacturer. Since this dilution gave high background for the negative
specimen, in the following experiments, the HRPO conjugate was diluted to 1: 100,000 which had
been used for the routine test in IMR. Ninety test sera for IgM-ELISA were randomly selected
from those examined by routine test in the Virology Division, IMR. The test specimen wasscored
as positive when its ELISA OD was equal to or greater than 2.0 of the negative control, according
to Lamet al. (1978). Using this diagnostic criterion on the 90 test sera in the previous routine test,
66 specimens were scored as positive while 24 specimens were negative, respectively.
RESULT
Preparation of HRPO-conjugated anti-flavivirus IgG
Six independent conjugations were carried out and the optimal dilution of the preparations
to distinguish positive (D2-infected C6/36 cell culture fluid) and negative (mock-infected C6/36
cell culture fluid) specimens were determined as described in the Materials and Methods. The
results summarized in Table 1 shows the dilution to prepare working solution and the amount of
the product. Although the dilution varied in a wide range from 1:25 to 1:6,400, the total amount
of the final product was estimated to be sufficient for use of 1,500 ELISA plates.
Production of D2 antigen in the infected C6/36 cells
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The ELISA antigen titer and volume of the specimens collected from D2-infected C6/36 cell
cultures were summarized in Table 2. The antigen titer was not detectable in the infected cell
homogenates which were prepared from secondarily harvested cells. The antigen titer in the
secondarily harvested fluid from D2-infected cells incubated at 28°C was not detectable in 2
harvests (19 and 23 September 1995), but another harvest on 16 February 1995 showed antigen
titer of 15 ELISA unit. In contrast, D2 antigen titer between 12 to 16 ELISA units was
reproducibly detectable in the culture fluid of D2 infected cells incubated at 37°C.
Table 1. Prearation of HRPO-conjugated anti-flavivirus IgG
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A nti-flavivirus IgG was prepared from high titered DHF patients' sera and conjugated with HRPO using
Wilson and Nakane's method (1978). The optimal dilution of the preparations was determined by the
checkerboard titration as described in the Materials and Methods.
Table 2. D2-antigen from infected C6/36 cell culture specimens
Dateof J?S?Pra£?rP Harvest Volume ELISA

















































I nfected culture fluid unless otherwise specified,
cell: infected cells solubilized in 1% Nonidet P-40 in PBS (-)
1st: harvest from primarily infected cells
2nd: second harvest from cells after harvesting 1st specimen
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Production of D2-specific MAb in hybridoma cell culture fluid
Culture fluid was collected from hybridoma cell lines, and its dilution to prepare working
solution in the antigen detection ELISA was measured using the detection system (2). In this test,
D2 antigen or negative control antigen was first captured on the ELISA plate by anti-flavivirus
IgG. After inactivation and washing, the plate was reacted with hybridoma culture fluids serially
diluted in PBS-T. The plate was washed and reacted with a constant dilution of HRPO-conjugated
anti-mouse IgG, followed by washing and color development. The dilution of hybridoma culture
fluid harvested on different dates was estimated by comparing the ELISA OD of serially diluted
test MAb with those of standard MAb supplied form CDC, USA, at its working dilution for
routine test in IMR. The dilution and volume of each hybridoma culture fluid are summarized in
Table 3. The results indicate that the total amount of hybridoma culture fluid is sufficient to make
28,000 ml working solution (or for 2,800 ELISA plates) for antigen detection ELISA.
IgM-ELISA using the C6/36 cell derived D2 antigen and D2 MAb from
hybridoma cell culture fluid
Encouraged by the results shown in Tables 2 and 3, we carried out IgM-ELISA on 90
patient's serum specimens using newreagents (C6/36 cell derived D2 antigen and D2 MAb from
hybridoma cell culture fluid). Previously carried out routine IgM-ELISA of these 90 test sera in
IMR scored 66 positives and 24 negatives as described in the Materials and Methods. In the
routine IgM-ELISA in IMR, the suckling mouse brain derived D2 antigen was diluted 1:100 to
prepare working antigen solution. The antigen titer of this working solution was estimated as 4.4
ELISA units by antigen detection ELISA. Therefore, D2-infected C6/36 cell culture fluid with 16
Table 3. Production of D2-MAb as culture fluid of
hybrodoma cell line (3H5-1-21)
Hybridoma culture fluid Working solution
Date of Volume TVI,,+-á"* Volume






























































*Estiamted from the chekcerboard titration in antigen
detection ELISA as described in the Materials and
Methods.
170
ELISA units antigen titer was diluted 1:2 to prepare working solution with antigen titer of 8
ELISA units. In this IgM-ELISA, detection system (2) was applied using D2-MAb in the hybri-
domaculture fluid which was harvested on 1 September 1995. This hybridoma culture fluid was
diluted 1:16 according to its assay result as shown in Table 3.
IgM-ELISA on September 1995 using these diluted antigen and MAb showed relatively
high background due to lower dilution (1:25,000) of HRPO-conjugated anti-mouse IgG. The
number of specimens scored as positive in this test was 51 by the new reagents (cell culture
derived D2 antigen at 1:2 dilution and hybridoma culture fluid at 1:16 dilution). Only additional
single specimen was scored positive when cell culture derived D2 antigen was used in combina-
tion with MAb for routine test. There were only 2 more specimens which were scored positive
when both D2 antigen and MAb for routine test were used. While, all 24 specimens which had
been determined as negatives by routine test showed negative results by the new reagents.
Therefore, the IgM-ELISA in this particular experiment possessed less sensitivity than routine
test, although its specificity was high (Table 4).
In the repeat experiment on 21 September 1995, higher dilution (1:100,000) of HRPO-
conjugated anti-mouse IgG was used in order to reduce the background, and concentration of D2
antigen and MAb was increased for better sensitivity. In this test, the number of positive speci-
mens were 62 and 63 when hybridoma culture fluid was diluted to 1:8 and 1:4, respectively
(sensitivity: 93.9%, and 95.5%). While the reagents for routine IgM-ELISA gave positive results
for 60 specimens (sensitivity: 90.0%). The difference among sensitivity in these tests using
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*Newantigen: D2 antigen prepared in D2-infected C6/36 cell culture fluid. IMR antigen: D2
antigen prepared from infected suckling mouse brains used at dilution for routine test in IMR.
"NewMAb: culture fluid of hybrodoma cell line (3H5-1-21) which secretes D2-specific MAb.
IMR: D2-specific MAb mosue ascitic fluid supplied from CDC, USA, diluted for routine test in
IMR.
***Sensitivity of the test comapred with the IgM-ELISA on the same panel of 90 test sera which
had been scored 66 positives and 24 negatives in the previous routine test. The test on 20
September 1995 gave high abckground due to lower dilution of HRPO-conjugated anti-mouse
IgG, therefore sensitivity in this particular test was under estimated.
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different reagests was not statistically significnat with confidence limit of greater than 95%.
In another repeat experiment on 22 September 1995, concentration of D2 MAb as hybri-
doma culture fluid harvested on 1 September 1995 was further increased, in combination with
undiluted D2-infected cell culture fluid as antigen. In this test, the number of positive specimens
was 63 and 64 when hybridoma culture fluid was diluted to 1:2 or undiluted, respectively (sen-
sitivity: 95.5%, and 97.9%). While the reagents used for routine test detected 65 positive speci-
mens(sensitivity: 98.5%). The difference in the sensitivity of the tests using new reagents and
routine reagents was not statistically significant. There was a single specimen which had been
scored as positive in the previous routine IgM-ELISA but gave negative result in the repeat ex-
periment using routine reagents. This specimen might have been scored as false positive in the
previous routine test or its IgM antibodies reacting to D2 antigen was inactivated during the
storage period.
DISCUSSION
Decentralizatoin of dengue IgM-ELISA is important for the rapid diagnosis which is es-
sential for proper case management, epidemiological surveillance and control of dengue. The
objective requires local production of key reagents: dengue antigen and MAb, in sufficient
quantities by less laborious method.
This objective appeared to be easily achieved when the titers of D2-infected C6/36 cell
culture fluid and D2-specific MAb in hybridoma culture fluid were measured in the antigen de-
tection ELISA. However, the IgM-ELISA on serum specimens from dengue patients using these
reagents showed that both antigen and MAb should be used at higher concentration than those
estiamted in the antigen detection ELISA. This discrepancy may be due to the different sen-
sitivity between antigen detection ELISA and IgM-ELISA. In the antigen detection ELISA,
significant amount of test antigen was captured by the catching antibody (anti-flaivivirus IgG) and
can be detectable with relatively low concentration of test reagents. In the IgM-ELISA on the
other hand, anti-dengue IgM which had first been captured, then reacts with a smaller amount of
D2 antigen. Therefore, much higher concentration of detecting reagents (D2 antigen and D2-
MAb) may have been reguired to get positive reaction. Therefore the dilution of these 2 reagents
should not be estiamted from the results of antigen detection ELISA. Independent test should be
carried out by comparing the performance of IgM-ELISA using newand routine reagents on a
panel of test sera. Production of higher concentration of D2 MAb will be achieved by preparing
mouseascitic fluid by D2 hybridoma cell line.
Wehave previously reported that increasing the incubation temperature of D2 or D3 in-
fected C6/36 cells from 28°C to 32°C or 37°C produced higher amount of viral antigen in the in-
fected culture fluid (Mohamed et al, 1985a). This observation was confirmed in the present ex-
periment. In a separate study, we have shown that the increased D2 antigen production in the
infected C6/36 cell line at elevated temperatures was accompanied by increased amount of in-
tracellular as well as extracellular viral RNA (Mangada et al, 1995). The study also showed that
C6/36 cell line could grow better at 28°C than at 32°C, and virtually negligible cell growth was
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observed at 37°C. The mechanism of this dissociation between the optimal temperature for cell
growth and virus growth remains to be investigated. For practical purpose to obtain sufficiently
high titered D2 antigen, the infected C6/36 cell line should be harvested 5 days after incubation
at 37°C. In our present study, 12-16 ELISA unit of antigen preparations were reporducibly
obtained under these conditions. Further incubation of the infected cells under fresh medium or
collecting infected cell homogenate did not appear useful for this purpose.
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